It makes sense to watch Wayfair Inc. (W) And ImmunoGen Inc. (IMGN)

Wayfair Inc. (NYSE: W) shares are 36.86% up in the year-to-date (YTD) period and have moved -3.98% or -$5.13 lower in the latest trading session. Comparatively, the stock is up 16.47% over the trailing 3-month period. If we look at the shorter duration, its week performance is 29.05% and 167.13% over the month.

Analyst Recommendations

On April 08, 2020, JP Morgan recommended the W stock is a Underweight, while earlier, Stifel had Downgrade the stock as a Hold on April 27, 2020. 32 analysts offering the recommendations for the stock have a consensus rating of 2.50 to suggest that the W stock is a “Moderate Sell. 5 of the 32 analysts rate the stock as a “Sell”, while 2 has rated it as “Underweight”. 12 recommend buying, with 0 rating it as an Overweight.

The stock currently trades at $123.68 and analysts tracking its performance over the next 12 months have a consensus estimate price target of $79.13. The forecasts give the Wayfair Inc. stock a price target range of $120.00 on the higher side while at least one analyst think the stock could plunge to a low of $35.00. The two limits represent an downside potential of -3.07% or -253.37%.

Earnings Forecast

Analysts estimate the earnings to decrease -5.70% in the current quarter to -$2.6, down from the -$1.62 reported in the same quarter a year ago. For the current year, earnings should grow to an average of -$8.68, up 19.50% from -$8.03 reported last year. Analysts also offered guidance for the next financial quarter, with their average projected EPS at between -$2.25 and -$0.37. Wall Street estimates earnings per share to be at an average of -$7.07 for the next year.

Insider Transactions Summary

According to SEC data, total insider shares purchases at the company stands at 105 over the last 12 months, while SEC filings reveal that there have been 123 insider sales over the same period. Insiders have purchases 1,724,547 shares while those sold by company executives and officers stand at 1,310,018. The last 3 months have seen insiders trade a total of 1,314,333 and 1,025,869 in purchases and sales respectively.

FLEISHER MICHAEL D, a Chief Financial Officer at the company, sold 6,196 shares worth $494572.0 at $79.82 per share on Apr 16. The Chief Financial Officer had earlier sold another 1,854 W shares valued at $165006.0 on Apr 17. The shares were sold at $89.00 per share. Macri Edmond (Chief Product/Marketing) sold 1,353 shares at $79.82 per share on Apr 16 for a total of $107993.0 while Oblak Steve, (Chief Merchandising Officer) sold 894 shares on Apr 16 for $71536.0 with each share fetching $80.02.

ImmunoGen Inc. (NASDAQ:IMGN), on the other hand, is trading around $3.94 with a market cap of $609.79M and analyst research firms have a positive stance on its shares. Analysts predict that the stock will reach $7.58 and spell out a more modest performance – a 48.02% return. Some analysts are even forecasting -$0.68 per share in earnings this year on a short term (1 year) basis.

Insider activity

Insiders have transacted a total of 9 times at ImmunoGen Inc. over the last 6 months, with insider purchases undertaken 3 times and accounting for 23,584 shares. Insider sales totaled 135,902 shares over the same period, with these deals completed in 6 transactions. Looking at these numbers, we realize that net purchases over that period are -3.0 shares. Insiders now hold a total of 1.94M shares after the latest sales, with -5.50% net shares purchased.

Major holders

Insiders own 0.50% of the company shares, while shares held by institutions stand at 75.60% with a share float percentage of 154.77M. Investors are also buoyed by the number of investors in a company, with ImmunoGen Inc. having a total of 256 institutions that hold shares in the company. The top two institutional holders are Redmile Group, LLC with over 14.64 million shares worth more than $74.74 million. As of Dec 30, 2019, Redmile Group, LLC held 8.40% of shares outstanding.

The other major institutional holder is Vanguard Group, Inc. (The), with the investment firm holding over 14.23 million shares as of Dec 30, 2019. The firm’s total holdings are worth over $72.62 million and represent 8.16% of shares outstanding.